Stanford University
Showing 801-900 of 2,211 Results
-
Sharon Wei Hung
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr Sharon Hung is a board-certified Internal Medicine physician who practices at the Stanford Internal Medicine Clinic in Santa Clara.
She received her MD degree at Northwestern Feinberg School of Medicine and completed her internal medicine residency training at Cedars-Sinai Medical Center.
Prior to working at Stanford, she was on faculty at the University of Arizona College of Medicine.
Currently, her clinical interests include both preventative medicine as well as managing chronic medical conditions such as diabetes, osteoporosis and steatotic liver disease.
She is the Director of Women’s Health for the Primary Care and Population Health department. Under this role, she is the course director of Stanford CME's Women's Health conference and the host for the Stanford CME's Women's Health vodcast which can be found on YouTube.
She offers group patient visits for counseling on osteoporosis and creates educational resources for primary care providers on various women’s health topics.
She is conversational in Spanish and Mandarin. -
Jennifer L. Hunter, PA-C
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioJennifer Hunter, PA-C is the Lead Advanced Practice Provider (APP) for the Emergency Department & Clinical Decision Unit (CDU) with experience in Adult Congenital Heart Disease (ACHD) and over 10 years of experience in Emergency Medicine. She is also a Clinical Assistant Professor and Educator-4-Care (E4C) at the Stanford School of Medicine & Masters of Science in PA Studies Program.
-
Zepeng Huo
Postdoctoral Scholar, Biomedical Informatics
BioConducting research on Foundation Models for medicine
-
Yusra Hussain, M.D.
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCollaborator in the HALF study
Collaborator in the PROMISE study
Primary Investigator, Bidet Pilot Study- 650-644-9230 -
Elizabeth W Hwang
Clinical Associate Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
Staff, Medicine - Med/Gastroenterology and HepatologyBioBoard Certification
Transplant Hepatology
Gastroenterology
Internal Medicine
Professional Education
Fellowship: Stanford University School of Medicine, Gastroenterology and Hepatology (2012)
Fellowship: Columbia University Medical Center, Transplant Hepatology (2009)
Residency: Columbia University Medical Center, Internal Medicine (2008)
Medical Education: Johns Hopkins University School of Medicine (2005)
Undergraduate: Johns Hopkins University (2001) -
Joo Ha Hwang, MD, PhD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Surgery
Current Research and Scholarly InterestsSpecialize in early detection of gastrointestinal malignancies including esophageal, gastric, pancreatic, bile duct & colon cancers. I have both a clinical & research interest in improving the early detection of gastric cancer in particular. I am the PI of the Gastric Precancerous conditions Study, a prospective study of patients with gastric intestinal metaplasia & other precancerous conditions which combines comprehensive clinical & endoscopic data with a large bio-specimen repository.
-
David Iberri
Clinical Assistant Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Hiroyuki Inoue
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Inoue is a physician-scientist who is enthusiastic about bridging research findings and clinical practice.
- a board certified cardiologist with 10+ years clinical experience
- experience in 400+ cases as a main operator in percutaneous coronary intervention, catheter ablation, and cardiac device implantation
- research expertise primarily in iPSCs, genome editing, and regenerative medicine
Dr. Inoue joined the Yang lab in 2022. His research aim is the development of novel regenerative therapeutics for heart failure. -
John P.A. Ioannidis
Professor of Medicine (Stanford Prevention Research), of Epidemiology and Population Health and by courtesy of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Eric Ip
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhancing drugs.
-
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multi-omic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include prediction modeling of survival, treatment response, recurrence, and CNS metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her ultimate goal is to be able to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.
-
Charlotte D. Jacobs M.D.
Drs. Ben and A. Jess Shenson Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsClinical Interests: general oncology, sarcomas. Research Interests: clinical trials in solid tumors.
-
Karen Blake Jacobson
Adjunct Clinical Assistant Professor, Medicine
BioDr. Jacobson is Postdoctoral Medical Fellow in the Division of Infectious Diseases and Geographic Medicine. She previously received her MD and MPH from Icahn School of Medicine at Mount Sinai and completed residency in Internal Medicine/HIV Primary Care at Yale. She is board certified in Internal Medicine and Infectious Diseases. Dr. Jacobson’s current research focus is on the epidemiology and natural history of SARS-CoV-2, and the interactions between SARS-CoV-2 and malaria in pregnancy in malaria endemic settings.
-
Prasanna Jagannathan
Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
BioI am an Infectious Diseases physician-scientist with a research program in human immunology of malaria and clinical trials of immune modulatory interventions. Our group has been conducting detailed longitudinal cohort studies in children and pregnant women in order to study how repeated malaria shapes the cellular immune response. We are also studying how malaria control interventions such as antimalarial chemoprevention and vector control shape the acquisition and/or maintenance of protective immunity to malaria. We have expanded this work to not only include studying the mechanisms driving naturally acquired immunity to malaria, but other infectious diseases, including SARS CoV-2. We have also lead and/or participated in studies evaluating therapeutic strategies for patients with mild to moderate COVID-19.
-
Fereshteh Jahanbani
Basic Life Research Scientist, Medicine - Med/Immunology & Rheumatology
BioDr. Jahanbani received her PharmD from Tehran University of Medical Sciences (TUMS) and PhD in pharmacology from Iran University of Medical Sciences (IUMS) and her postdoctoral degree from Case Western Reserve University (CWRU) and University of California, Santa Cruz (UCSC). She joined Stanford Center for Genomics and Personalized Medicine in June 2012. Her work is focused on better understanding the etiology of chronic complex conditions and multi-morbidity using multi-omics and precision health approaches. She has been leading ME/CFS related disorders multi-omics study combining the power of both family and population approaches and also cofounded “Research To The People at Stanford Program”.
-
Prachee Jain
Postdoctoral Scholar, General Internal Medicine
Current Research and Scholarly InterestsIn her research, Prachee Jain is studying the design and implementation processes of intelligent technologies, such as AI-enabled robots, conversational agents and virtual assistants, and how they affect the interactions between humans in teams.
-
Sajid Jalil
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Jalil is a board-certified, fellowship-trained transplant hepatologist (liver doctor) and gastroenterologist at the Stanford Health Care Digestive Health Center in San Jose, California. He is also a clinical associate professor in the Department of Medicine, Division of Gastroenterology and Hepatology, at Stanford University School of Medicine.
Dr. Jalil has extensive experience helping patients with a range of liver- and digestion-related conditions. He specializes in liver transplantation, and his other clinical interests include all forms of hepatitis, cirrhosis of the liver, fatty liver disease, polycystic liver disease, and primary sclerosing cholangitis (swelling and scarring of the bile ducts). He has also volunteered in initiatives to offer free colonoscopy and hepatitis B screenings to underserved ethnic populations.
His research interests include improving mental health by enhancing treatment access for patients with alcohol use disorder causing alcoholic liver disease. He has also studied swallowing problems, liver disease in pregnancy, living liver donation, and the use of artificial intelligence in treating nonalcoholic fatty liver disease and viral hepatitis. In addition, Dr. Jalil wrote a chapter on bile secretion and cholestasis (diminished bile flow) for the fifth edition of Yamada’s Textbook of Gastroenterology.
Dr. Jalil has published in numerous peer-reviewed journals, including World Journal of Hepatology, Liver Transplantation, and the Journal of Clinical Gastroenterology. Additionally, he has served as a reviewer for Pancreatology and as an abstract reviewer for the American Gastroenterological Association (AGA) and the Ohio Chapter of the American College of Physicians. He has presented his research at meetings and conferences worldwide on a range of topics, including the timing of pregnancy after liver transplantation.
Dr. Jalil is an AGA fellow and a member of the American Association for the Study of Liver Diseases, American College of Gastroenterology, and American Society for Gastrointestinal Endoscopy. -
Mehrnaz Nicole Jamali MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. M. Nicole Jamali focus has been in leadership, scientific innovation and streamlining business ventures. Over the past 20 years since graduation from Stanford Internal Medicine Residency, she has held National Positions in AMA as Western Caucus Chair and Appointee to Joint Commission Board. She was reelected to Board of Joint Commission three terms for total of 9 years. She helped rewrite multiple TJC Standards including creation of the Stroke Center of excellence standards and annual "new ideas section of the board". At AMA she authored and passed multiple House rules on variety of subjects affecting thousands of providers and healthcare centers. Her experiences in private practice, group practice, Hospitalist, Insurance Directorship lead to multiple innovative projects including first e-prescription covering both meds and DME in 1999 titled eRemedy,. She then created the first wrong site surgery device which was patented. This project lead to creation of first Transplant App called TPOD which was then simplified to TAPP. It was beta tested in USC and perfected in UCSF Transplant.
Her work with various Insurance companies resulted in streamlined programs and teaching modules improving patient access to health care and millions of dollars in hospital savings of unnecessary admissions.
Her work in creation and streamlining and connecting with local Primary Care providers resulted in rapid expansion of the Hospitalist program of local Hospital by 300%
She is currently interested in Haptic and AI technologies in Medicine and providing 24/7 care to our veterans in remote locations or even the battlefield.
She is currently Clinical Associated Professor and the lead Hospitalist in the new Stanford Cardiovascular Hospitalist Program and enjoys the daily interaction with patients . She truly believes that her mission in life is to be at the bedside of ill patients. She treats them as one of her own family. It is not atypical for her to hand out her personal phone number to make sure they feel safe even when discharged. -
Mathangi Janakiraman
Postdoctoral Scholar, Gastroenterology
Current Research and Scholarly InterestsAs a postdoctoral scholar, I am studying the gut ecosystem, gut functionality nad neuroimmune interactions during aging and age-associated diseases like AD, and the role of fermented food in modulating gut health. I expect to be able to show that dietary modifications can help with healthy aging and to contribute to possibly leveraging dietary interventions therapeutically in age-associated diseases.
-
John Jay Jernick
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsHealth services research; guided self-care; health, education; outcome oriented decision processes.
-
Hanlee P. Ji
Professor of Medicine (Oncology) and, by courtesy of Electrical Engineering
On Leave from 03/01/2024 To 06/30/2024Current Research and Scholarly InterestsCancer genomics and genetics, translational applications of next generation sequencing technologies, development of molecular signatures as prognostic and predictive biomarkers in oncology, primary genomic and proteomic technology development, cancer rearrangements, genome sequencing, big data analysis
-
Xiaolin Jia
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsQuality improvement, palliative care
-
Can "Angela" Jiang
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Can "Angela" Jiang is a board certified family physician who enjoys caring for the whole family, from newborn care to geriatrics. She has special interests in women's health, adolescent health, pediatrics, and medical student education. She specializes in primary care procedures including gynecologic procedures.
Prior to medical school, Dr. Jiang was a high school biology teacher in Chicago with Teach for America and loves combining her passions for teaching and medicine on a daily basis at Stanford Family Medicine. Dr. Jiang also teaches residents at the Stanford Health Care-O'Connor Hospital residency program and is the director of the O’Connor-Stanford Leaders in Education Residency Program (OSLER). Dr. Jiang is also passionate about community outreach and works with the Stanford Youth Diabetes Coaches Program.
Outside of clinic, she enjoys hiking, reading, group fitness classes, traveling, and running after her two young kids. -
Jocelyn Jiao, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Assistant Professor, Medicine - Primary Care and Population HealthBioDr. Jiao is a fellowship-trained, board-certified neurologist with the Movement Disorders Center at Stanford Health Care. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences.
Dr. Jiao has extensive experience providing comprehensive care for patients with different types of movement disorders, including Parkinson’s disease. She is fellowship-trained in both movement disorders and hospice and palliative medicine. Dr. Jiao is developing an interdisciplinary neuropalliative clinic that emphasizes planning for the future and maximizes quality of life for people living with chronic neurological illness.
Dr. Jiao’s research efforts include a pilot study assessing the impact of deep brain stimulation (DBS) as a treatment for Parkinson’s-related motor symptoms upon mood and pain. Specifically, this work focuses on identifying correlations between DBS targets and reductions in medications that address depression, anxiety, and impulsivity symptoms that result from Parkinson’s treatments. Dr. Jiao has also completed a pilot study focused upon narrative medicine interventions for people living with Parkinson’s disease.
Dr. Jiao has published her work in multiple peer-reviewed journals, including Pain Medicine and the Journal of Neurosurgery. Dr. Jiao is a member of the American Academy of Neurology, the International Parkinson and Movement Disorder Society , and the International Neuropalliative Care Society. -
Jenelle Asha Jindal
Affiliate, Med/BMIR
BioDr. Jenelle Jindal is currently a research collaborator in the lab of Dr. Nigam Shah. She strongly believes in the need for AI to augment healthcare, and her research interests focus on evaluating new use cases for AI in healthcare.
She has experience as an operator within the healthcare system, serving as medical director at El Camino Hospital in Silicon Valley launching telestroke and 24/7/365 thrombectomy care. Subsequently the hospital was recognized by the Joint Commission with a new higher level of Thrombectomy Capable Certification. She also completed a tour of duty helping in the Emergency Operations Center of Santa Clara County during the COVID-19 pandemic assisting with antigen testing deployment and increasing vaccination uptake.
She is also an experienced neurologist, caring for thousands of patients as a practicing physician. Her clinical focus has included treating strokes, brain hemorrhage, epilepsy, and neurodegenerative disease in the emergency room, ICU, and hospital wards. She was founder and CEO running a private medical practice for nearly 7 years and served as a Medical Advisory Board member of the Pacific Stroke Association.
She is a graduate of Stanford University, Yale School of Medicine, and completed residency and fellowship at the Harvard hospitals of Mass General and Brigham & Womens.
Recent publications:
--Ensuring useful adoption of GenAI in healthcare: https://bit.ly/3Tq9eYn
--Zero-shot clinical trial patient matching with LLMs: https://arxiv.org/abs/2402.05125
--Medalign preprint using LLMs to query medical records data: https://arxiv.org/abs/2308.14089
LinkedIn: www.linkedin.com/in/jenellejindal/ -
Esther M. John
Professor (Research) of Epidemiology and Population Health and of Medicine (Oncology)
Current Research and Scholarly InterestsDr. John has extensive expertise in conducting population-based epidemiologic studies and has led as Principal Investigator multiple large-scale studies, including multi-center studies with a study site in the San Francisco Bay Area with its diverse population. Many of her studies and collaborations investigated cancer health disparities. Her research has focused on the role of modifiable lifestyle factors (e.g., body size, physical activity, diet), hormonal factors, early-life exposures, genetic variants, and gene-environment interactions; differences in risk factors by race/ethnicity, breast cancer subtypes, and prostate cancer subtypes; risk factors for familial breast cancer and second primary breast cancer, as well as prognostic factors related to survival disparities.
As Principal Investigator, Dr. John has led a number of studies conducted in the San Francisco Bay Area, including:
- the Northern California site of the Breast Cancer Family Registry, an on-going prospective multi-generational cohort of over 13,000 families established in 1995 at six international sites;
- the Northern California site of the WECARE Study that investigates risk factors for second primary breast cancer;
- the California site of the Breast Cancer Health Disparities Study that investigated genetic variability and breast cancer risk and survival in Hispanic and non-Hispanic white populations in the context of genetic admixture;
- the Breast Cancer Etiology in Minorities (BEM) Study, a pooled analysis of risk factors for breast cancer subtypes in racial/ethnic minorities;
- the San Francisco Bay Area Breast Cancer Study, a population-based case-control study in nearly 5,000 Hispanic, African American and non-Hispanic white women that investigated the role of modifiable lifestyle factors and other risk factors;
- the San Francisco Bay Area Prostate Cancer Study, a population-based case-control study of lifestyle and genetic risk factors for advanced and localized disease.
These studies collected and pooled extensive data and biospecimens and continue to support numerous ancillary studies, collaborations and international consortia and have contributed to a better understanding of cancer risk and survival in racial/ethnic minority populations.
Dr. John is also a founding PI of the LEGACY Girls Study, an on-going prospective cohort established in 2011 that investigates early life exposures in relation to pubertal development outcomes, breast tissue characteristics, and behavioral and psychosocial outcomes in the context of having a family history or breast cancer. -
Roy Mattathu John, MD, PhD, FRCP
Clinical Professor, Medicine - Cardiovascular Medicine
BioDr. John is a fellowship-trained cardiologist with more than 25 years of experience. He is a clinical professor in the Department of Medicine at Stanford University School of Medicine.
He originally earned board certification in clinical cardiac electrophysiology in 1996 and has continued to recertify. He also has earned board certification in cardiovascular disease and internal medicine.
Dr. John diagnoses and manages all forms of cardiac arrhythmias including atrial fibrillation and ventricular arrhythmias. His special interests include catheter ablation for SVT, atrial arrhythmias, pacemaker and defibrillator implants, and lead extraction.
He has conducted extensive research. He has participated in large multi-center clinical trials, including over 30 studies as a primary investigator of drugs, devices, and ablation techniques. He helped pioneer a new way to manage scar-related ventricular tachycardia. He also helped develop innovations in cardiac pacemaker technology.
Dr. John has authored over 200 publications that include 126 original research papers. They have appeared in reputed journals such as the New England Journal of Medicine, Circulation, Lancet, Journal of the American College of Cardiology, European Heart Journal, Heart Rhythm, Journal of Cardiovascular Electrophysiology, and many more. Topics have included innovative, new techniques and technologies for the treatment of supraventricular arrhythmias, atrial fibrillation, ventricular tachycardia, catheter ablation, lead extraction, cardiac pacing, and defibrillation.
He was a member of the editorial board for Circulation and is currently on the editorial board of the publications Heart Rhythm Journal, Arrhythmia and Electrophysiology, Journal of Cardiac Electrophysiology, and Journal of Innovations in Cardiac Rhythm Management.
Dr. John also has written several chapters for medical textbooks such as Harrison’s Principles of Internal Medicine, Zipes Textbook on Cardiac Electrophysiology - Cell to Bedside, Conn’s Current Therapy, Electrical Disorders of the Heart, Cardiac Mapping, and many more.
He has made invited presentations to his peers at scientific sessions of the Heart Rhythm Society, American Heart Association, American College of Cardiology, and Heart Failure Society. He has delivered more than 60 national and international lectures. Subjects include cardiac pacing, defibrillation, heart failure, and arrhythmia management including catheter ablation for arrhythmias.
Dr. John is a fellow of the American College of Cardiology, Heart Rhythm Society, and Royal College of Physicians of London.
He has volunteered his time and expertise to provide free cardiac care to underserved patients in Bolivia, India, and Kenya. -
Cati G. Brown-Johnson
Sr Res Scholar, Primary Care and Population Health
Current Role at StanfordSenior Research Scholar | Implementation and Social Science
-
Tyler Johnson
Clinical Associate Professor, Medicine - Oncology
BioDr. Tyler Johnson is a physician, author, educator, and humanitarian. At the Stanford University School of Medicine, he has held an appointment as a clinical assistant professor for six years. A medical oncologist, Dr. Johnson sees patients with all types of gastrointestinal malignancies and particularly focuses on patients with neuroendocrine tumors, colon cancer, and pancreas cancer.
Dr. Johnson also serves as a leader of the Stanford inpatient oncology services, including supervising the oncology housestaff service. He is responsible, in conjunction with other leaders, for multiple major improvements in the functioning of Stanford hospital.
Dr. Johnson views the practice of medicine largely as an educational endeavor. To that end, for many years he has taught medical students, residents, and fellows—including hosting them as temporary and longer-term apprentices in his oncology clinic and working with them on the inpatient housestaff oncology service. He emphasizes diversity and inclusion in his mentoring efforts and has worked tirelessly to promote the professional development of medical trainees across the training spectrum--from undergraduates to oncology fellows.
The winner of multiple Stanford Medicine teaching awards, Dr. Johnson has established himself as a regional and increasingly as a national leader and innovator in the education of oncology fellows, including by developing novel teaching methods that have been presented across the country, including at national meetings. He also heads the Stanford oncology department’s curricular development and as part of that had developed a novel curricular approach that centers the needs and teaching abilities of oncology fellows. He also works as one of the principal faculty members of the Stanford Educators-4-CARE program.
Dr. Johnson and his co-host, Henry Bair, became concerned about the loss of a shared sense of meaning in the medical profession and, together, have taught multiple classes in the Medical School and, in the spring of 2022, founded The Doctor's Art podcast. Over the remainder of 2022, this podcast became one of the five most listened-to medical podcasts in the nation, with a growing national and international listenership.
Finally, Dr. Johnson is an author with a growing reputation for insightful analysis of the intersection of medicine, ethics, and spirituality. His writings has been featured by Religion News Service, the Salt Lake Tribune, BYU Studies, Dialogue, and The San Jose Mercury News, where he is a regular contributor. -
Laura Johnston
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsClinical research in allogeneic and autologous hematopoietic cell transplantation (HCT), more specifically, allogeneic transplantation and graft versus host disease. Exploring methods of improving prevention and treatment of GVHD as well as the long term follow-up and/or quality of life of affected patients.
-
Andrea Jonas
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Andrea Jonas is a Clinical Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University. She completed her undergraduate studies in chemistry and physics at Harvard University. She received her MD from Johns Hopkins University, where she stayed on to complete residency training in internal medicine on the Osler Medical Service. She pursued fellowship training in pulmonary and critical care medicine at Stanford University, where she additionally completed a research fellowship in health care innovation and systems design as part of the Clinical Excellence Research Center. Her research interests include integrating technological innovations into healthcare system practices to improve delivery of pulmonary and ICU services.
-
Evaleen Kay Jones
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsEvaleen Jones has a passion for Global Health Education. She is President, Founder of Child Family Health International, a non-profit 501©(3) $2 million organization that oversees the placement of 650+l students in immersion programs (a mini 'peace corps') in developing countries. She is also Board Certified in Addiction Medicine (American Society Addiction Medicine and a certified instructor of Mindfulness through the Center for Mind Body Medicine.
-
Maria Juarez-Reyes
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Juarez-Reyes received her PhD in Health Psychology, MD and Internal Medicine residency training from the University of California at San Francisco. Her focus during medical training was in Behavioral Medicine. In 2010, she became board certified in Integrative Medicine through American Board of Integrative Holistic Medicine. She is currently Assistant Clinical Professor in the Division of Primary Care and Population Health, Department of Medicine, Stanford University. She serves as Site Director for Internal Medicine Residency program at Stanford. She developed “Beyond Stress”, a six-week group intervention for patients with stress, anxiety, and depression and is the Director of Behavioral health Group Medical Visits. This intervention has now been translated into Spanish, Mas Alla del Estres, and it is delivered to community based Spanish speaking cancer patients.
Her current research evaluates integrative behavioral health group medical visits and the relationship to anxiety, depression, burnout, and sleep in primary care and Spanish speaking community-based populations. Her other health disparities research has been in tobacco cessation practices of community-based providers, breast cancer screening follow-up in Latinx women, Latinx adolescent reproductive behavior, medication eligibility criteria effects in ethnic subgroups, and TB treatment in urban county jails. She enjoys travel, walking with friends, anything science fiction and spending time with her family. -
Nicholas Hedemann Juul
Instructor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsMolecular and cellular biology of the distal lung
High altitude medicine -
Deborah Kado
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioDr. Kado is a board-certified, fellowship-trained doctor specializing in geriatrics. She serves as co-director of the Stanford Longevity Center. She is a professor of medicine and chief of research for the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health. She is also the Director of the Geriatric Research, Education, and Clinical Center (GRECC) at VA Palo Alto Health Care System.
For each patient, Dr. Kado prepares a personalized care plan. Her objective is to help all individuals maintain the best possible health and quality of life as they age.
A special interest of Dr. Kado is bone health. She has conducted extensive research focused on osteoporosis and the related disorder hyperkyphosis.
Since joining the UCLA faculty in 2000, she has received continuous funding for her research from the National Institutes of Health (NIH).
She has over 100 peer-reviewed publications of her research findings in the Journal of Bone and Mineral Research, Osteoporosis International, Journal of Gerontology and Medical Sciences, Journal of Geriatric Oncology, Nature Communications, and other peer-reviewed journals.
In 2007, she defined hyperkyphosis as a new geriatric syndrome. Her discoveries in this field were first featured in the American College or Physician’s premier internal medicine journal Annals of Internal Medicine. Later, they also appeared in a dedicated chapter in UpToDate, the electronic resource providing evidence-based clinical decision support for doctors worldwide.
Prior to coming to Stanford, Dr. Kado practiced at UC San Diego where she started a dedicated osteoporosis clinic for patient care and research. She later broadened her research interests beyond musculoskeletal aging to study other aging-related topics such as the gut microbiome in older men and the effects of cancer treatments on aging in newly diagnosed breast cancer patients.
Dr. Kado is a California native. She trained at UCSF and UCLA. She also earned a Master of Science degree in epidemiology at the UCLA School of Public Health, sponsored by the John Hartford Foundation.
She is a member of the American Geriatrics Society, American Society of Bone and Mineral Research, Gerontological Society of America, The Endocrine Society, and other professional organizations. She co-chairs the NIH National Institute on Aging Workshop for the American Society of Bone and Mineral Research. She also participates in the Bone Health Working Group of the Society for Women’s Health Research. -
James Kahn
Professor of Medicine (General Medical Disciplines), Emeritus
Current Research and Scholarly InterestsMy initial research activities involved antiretroviral and novel therapeutic treatments of HIV infection, understanding elements of HIV pathogenesis associated with acute HIV infection and post exposure prevention. My most recent scholarly activities concentrate on working as a team to capitalize on the data stored in electronic medical records, HIV disease modeling and using electronic medical records for outcome research and developing a mentorship program for early career scientists.
-
Neil M. Kalwani
Clinical Instructor, Medicine - Cardiovascular Medicine
BioNeil Kalwani, MD, MPP is a Clinical Instructor in the Division of Cardiovascular Medicine and Director of Preventive Cardiology at the VA Palo Alto Health Care System. He attended college at Yale University and completed graduate degrees in medicine and public policy at Harvard University. He trained in internal medicine at Brigham and Women’s Hospital before arriving at Stanford in 2018 for fellowship in cardiovascular medicine, during which he served as Chief Fellow. He then completed a postdoctoral fellowship through the Stanford-AHRQ Health Services Research Training Program in the Department of Health Policy. His clinical focus is in general and preventive cardiology and echocardiography. He practices at the VA Palo Alto Health Care System and at Stanford Health Care.
Dr. Kalwani's research focuses on the evaluation of policies and care delivery innovations designed to improve the value of care for patients with cardiovascular disease. -
Afrin N. Kamal, MD MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioAfrin Kamal is a board-certified gastroenterologist, who trained at Washington University in internal medicine, Cleveland Clinic in gastroenterology/hepatology, and most recently Stanford University in esophageal and motility diseases. Afrin shares a clinical passion in esophageal motility diseases with an an overlapping interest in health services and outcomes research.
-
Ahmad Kamal, MD, MS
Clinical Associate Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
BioDr. Kamal graduated from the University of California at Irvine in 1995 with a B.S. in Biology and received his M.D. from Harvard Medical School in 1999. He completed his residency in Internal Medicine and fellowship in Gastroenterology at Stanford in 2006, during which time he also earned an MSc in Clinical Epidemiology.
In addition to serving as associate chief of the division of gastroenterology at SCVMC, Dr. Kamal is vice chair of internal medicine and director of the clinical research pathway, an innovative program that provides mentoring and protected time for clinical research to internal medicine residents. He is active in teaching trainees at all levels and received an outstanding mentor award from Stanford's biodesign program.
Dr. Kamal has been named a fellow of the American Gastroenterological Association and has been recognized several times in the "Top Doctors" list. He received the Hospital Quality Institute's C. Duane Dauner Award for his work in specialty care transformation and was one of 6 recipients of Silicon Valley Business Journal's Excellence in Healthcare Award. During the COVID-19 pandemic, he served as Director of Health Systems Preparedness for Santa Clara County and was awarded a Medal for Outstanding Service by the Board of Supervisors.
Dr. Kamal has also been active in clinical and health services research, authoring over 20 peer-reviewed publications, 40 abstracts, and 7 book chapters. -
Vishnu Priya Kanakaveti
Postdoctoral Scholar, Oncology
Current Research and Scholarly InterestsI am interested in elucidating molecular mechanisms of MYC-driven drug resistance and immune evasion in cancer using computational and experimental models.
-
Beverley Kane
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioBeverley Kane, MD, was Board Certified in Family Medicine, then completed fellowships in Ob-Gyn (San Francisco Children's Hosptial) and Sports Medicine (London Univeristy). She has worked in the private practice of sports medicine; in medical informatics, specializing in doctor-patient communication (WebMD); and in stress management with her private practice, Horsensei Equine-Assisted Learning & THerapy (HEALTH). Her latest book, "Equine-imity--Stress Reduction and Emotional Self-Regulation in the Company of Horses," published 27 March 2021, can be seen at http://equine-imity.com/
-
Guson Kang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He has expertise in complex coronary interventions, transcatheter aortic and mitral valve replacements, transcatheter mitral valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, and paravalvular leak closure.
A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital. -
Peter Kao
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsOur research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Robert Kaplan
Adjunct Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsHealth services research
Studies on the cost and quality of health care
Health outcome measurement
Social determinants of health
